Abstract
Previous evaluation of lymphocytes taken from patients with Wiskott-Aldrich syndrome (WAS) and other X-linked immunodeficiencies has revealed deficiencies of a lymphocyte sialoglycoprotein with a relative molecular mass of 115 kD (designated gpL-115) found in normal lymphocytes. The development of monoclonal antibodies to gpL-115 has permitted the detection of molecular heterogeneity in gpL-115 from the lymphocytes of immunodeficient patients. When lymphocytes from normal individuals were analyzed by immunoblotting, gpL-115 with only a single molecular species (115 kD) was detected. Lymphocytes from 17 immunodeficient patients were analyzed after overnight incubation. Two patients had no gpL-115 with an Mr of 115 kD, but gpL-115 with an Mr of either 95 or 135 kD was detected. Nine patients had gpL-115 with Mr equally of 95 and 115 Kd. Other patients exhibited gpL-115 with combinations of 95, 115, and 135 kD. The heterogeneity of the degraded gpL-115 suggests that WAS and other X-linked immunodeficiencies are due to a series of abnormalities, all of which involve gpL-115, and may explain the clinical heterogeneity of the diseases.
Full text
PDF![595](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5a/424136/79598b43a836/jcinvest00113-0285.png)
![596](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5a/424136/a1f29504d405/jcinvest00113-0286.png)
![597](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5a/424136/b5754b6a8bcc/jcinvest00113-0287.png)
![598](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5a/424136/9715a0bc44de/jcinvest00113-0288.png)
![599](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5a/424136/7bef48212f43/jcinvest00113-0289.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Axelsson B., Hammarström S., Finne J., Perlmann P. The large sialoglycoprotein of human lymphocytes. II. Biochemical features. Eur J Immunol. 1985 May;15(5):427–433. doi: 10.1002/eji.1830150503. [DOI] [PubMed] [Google Scholar]
- Axelsson B., Hammarström S., Robertsson E. S., Aman P., Perlmann P., Mellstedt H. The large sialoglycoprotein of human lymphocytes. I. Distribution on T and B lineage cells as revealed by a monospecific chicken antibody. Eur J Immunol. 1985 May;15(5):417–426. doi: 10.1002/eji.1830150502. [DOI] [PubMed] [Google Scholar]
- Brown W. R., Barclay A. N., Sunderland C. A., Williams A. F. Identification of a glycophorin-like molecule at the cell surface of rat thymocytes. Nature. 1981 Feb 5;289(5797):456–460. doi: 10.1038/289456a0. [DOI] [PubMed] [Google Scholar]
- Kenney D., Cairns L., Remold-O'Donnell E., Peterson J., Rosen F. S., Parkman R. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood. 1986 Dec;68(6):1329–1332. [PubMed] [Google Scholar]
- O'Farrell P. H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975 May 25;250(10):4007–4021. [PMC free article] [PubMed] [Google Scholar]
- Parkman R., Rappeport J., Geha R., Belli J., Cassady R., Levey R., Nathan D. G., Rosen F. S. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med. 1978 Apr 27;298(17):921–927. doi: 10.1056/NEJM197804272981701. [DOI] [PubMed] [Google Scholar]
- Parkman R., Remold-O'Donnell E., Cairns L., Rappeport J. M., Cowan M., Ammann A., Kenney D., Potter N., Rosen F. S. Immune abnormalities in patients lacking a lymphocyte surface glycoprotein. Clin Immunol Immunopathol. 1984 Dec;33(3):363–370. doi: 10.1016/0090-1229(84)90307-6. [DOI] [PubMed] [Google Scholar]
- Parkman R., Remold-O'Donnell E., Kenney D. M., Perrine S., Rosen F. S. Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome. Lancet. 1981 Dec 19;2(8260-61):1387–1389. doi: 10.1016/s0140-6736(81)92802-6. [DOI] [PubMed] [Google Scholar]
- Remold-O'Donnell E., Kenney D. M., Parkman R., Cairns L., Savage B., Rosen F. S. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med. 1984 Jun 1;159(6):1705–1723. doi: 10.1084/jem.159.6.1705. [DOI] [PMC free article] [PubMed] [Google Scholar]